Alaunos Therapeutics

PriceAlaunos Therapeutics

TCRT

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

Historical stock price chart and annual return over the past years

-99%

5 years

% Total

TCRT
-63%

5 years

Annual Return

TCRT